Analysis finds ties between pharmaceutical industry and federal government are deepening; Mississippi readies a Medicaid work requirement waiver; research identifies danger of interactions between herbal supplements and prescription medications.
An analysis from Kaiser Health News found that the ties between the pharmaceutical industry and the federal government are deepening. Alex Azar, the newly confirmed HHS secretary, is just the latest example of the so-called “revolving door” connecting the federal government and the drug industry. There are more than 300 former congressional staffers who work for pharma companies or a pharma lobbying firm and nearly a dozen former employees of the drug industry now work for the government.
Although Medicaid beneficiaries in Kentucky just sued the government over new work requirements to receive benefits, Mississippi is preparing its own waiver request to implement the same restriction. According to The Hill, the state is seeking a 5-year waiver to require able-bodied adults to participate in at least 20 hours of workforce training every week. If beneficiaries aren’t participating in approved activities, such as working, volunteering, or enrolled in a drug treatment program, they will be kicked off Medicaid. Mississippi’s waiver request differs from Kentucky, which had expanded Medicaid and targeted its requirements at those newly eligible beneficiaries.
New research has found that mixing common herbal supplements with prescription medications can result in dangerous interactions. TIME reported that the challenge is that people often don’t tell their healthcare providers what over-the-counter drugs and supplements they take. Herbals supplements can result in medications being less effective. The research found that of 49 cases of adverse drug reactions reviewed, herb—drug interactions were probable for 51%.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More